Does IMIDAPRIL Cause Interstitial lung disease? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Interstitial lung disease have been filed in association with IMIDAPRIL. This represents 4.9% of all adverse event reports for IMIDAPRIL.
5
Reports of Interstitial lung disease with IMIDAPRIL
4.9%
of all IMIDAPRIL reports
0
Deaths
4
Hospitalizations
How Dangerous Is Interstitial lung disease From IMIDAPRIL?
Of the 5 reports, 4 (80.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMIDAPRIL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does IMIDAPRIL Cause?
Altered state of consciousness (10)
Toxicity to various agents (10)
Hypotension (9)
Hypoglycaemia (8)
Intentional overdose (8)
Hypokalaemia (7)
Stevens-johnson syndrome (7)
Pancreatitis acute (6)
Renal impairment (6)
Decreased appetite (5)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which IMIDAPRIL Alternatives Have Lower Interstitial lung disease Risk?
IMIDAPRIL vs IMIGLUCERASE
IMIDAPRIL vs IMIPENEM
IMIDAPRIL vs IMIPRAMINE
IMIDAPRIL vs IMIQUIMOD
IMIDAPRIL vs IMITREX